ENANTA PHARMACEUTICALS, INC
Asset & Liabilities Breakdown
Asset Breakdown FY2023
Total Assets: $462.3M
Liabilities Breakdown FY2023
Total Liabilities: $245.5M
Asset Breakdown
Total Assets: $462.3M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $85.4M | 18.5% |
| Accounts Receivable | $8.6M | 1.9% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $11.9M | 2.6% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $356.4M | 77.1% |
Liabilities Breakdown
Total Liabilities: $245.5M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $4.1M | 1.7% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $241.4M | 98.3% |